Pharmacology’s Anthony Berdis discusses new breast cancer findings

Why some breast tumors resist chemo

DailyRx: Researchers have found a particular marker may be able to predict if a woman’s breast cancer will respond to taxane chemotherapy. “This exciting data first provides a new way to attack cancer cells,” said Anthony Berdis, assistant professor of pharmacology. “Secondly, this information provides a way to screen patients in advance to see if they would benefit from this anti-cancer agent. Both features will provide better ways to treat patients with breast cancer.”